Clinical Trial Update: An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of CNTO 136 in patients with active lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• CNTO 136

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Lupus Nephritis | Phase 2 | Status: COMPLETED